Cipla, Lupin eye 2016 refis for bridge loans

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cipla, Lupin eye 2016 refis for bridge loans

Pills_medicine_230px

Indian pharmaceutical companies Cipla and Lupin are set to tap the syndicated loan market in 2016 to refinance bridge loans they raised for acquisitions in early 2015.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article